| Dr Anne Yichen Feng, MD | |
|
90 Bergen St Ste 8100, Newark, NJ 07103-2425 | |
| (973) 972-2548 | |
| Not Available |
| Full Name | Dr Anne Yichen Feng |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology |
| Location | 90 Bergen St Ste 8100, Newark, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972248094 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | ----- (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Anne Yichen Feng, MD 400 Claremont Ave Unit 6041, Jersey City, NJ 07304-4380 Ph: (919) 946-0797 | Dr Anne Yichen Feng, MD 90 Bergen St Ste 8100, Newark, NJ 07103-2425 Ph: (973) 972-2548 |
News Archive
A new book published by the Pan American Health Organization (PAHO) predicts that the 21st century will become the "century of vaccines" thanks to rapid developments in the field of immunization.
Asuragen, Inc. announced today the results of a collaborative study with scientists at the M.I.N.D. Institute at the University of California Davis evaluating a new PCR technology that reproducibly reports mutations associated with Fragile X syndrome (FXS).
Pharmaceutical company Novartis "has spoken out following criticism about its challenge to India's patent laws, insisting that access to life-saving drugs is not under peril by the move," Pharma Times World News reports. The case, which the Indian Supreme Court is scheduled to hear next month, challenges "Indian patent law, notably Section 3(d), which states that a modification of a known chemical composition is non-patentable," the news service writes.
Exelixis, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for cabozantinib as a treatment for patients with progressive, unresectable, locally advanced, or metastatic medullary thyroid cancer (MTC).
NILE features low-profile, robust implants and intuitive and light ergonomic instruments, intended to provide stabilization between the spine and the rod, and to allow for reduction, translation, compression and distraction while sparing the anatomy...
› Verified 2 days ago
Dr. Evelyne Kalyoussef, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 90 Bergen Street, Suite8100, Newark, NJ 07103 Phone: 973-972-4588 | |
Christen Lennon Caloway, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 90 Bergen St Ste 8100, Newark, NJ 07103 Phone: 973-972-2548 Fax: 973-972-8567 | |
Dr. Yu-lan Mary Ying, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 90 Bergen Street Suite 8100, Newark, NJ 07103 Phone: 973-972-4588 | |
Eric T Carniol, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 90 Bergen St, Suite 8100, Newark, NJ 07103 Phone: 973-972-2548 | |
Dr. Jean Anderson Eloy, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 90 Bergen St, Suite 8100, Newark, NJ 07103 Phone: 973-972-4588 Fax: 973-972-3767 | |
Soly Baredes, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 90 Bergen St, Doc-7200, Newark, NJ 07103 Phone: 973-972-2400 Fax: 973-972-2988 | |
Andrey Filimonov, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 90 Bergen St Ste 8100, Newark, NJ 07103 Phone: 973-972-2548 |